Tyra Biosciences, Inc. (TYRA) — Financial statements
Income statement, balance sheet, and cash flow for Tyra Biosciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 103↑28.5% | 80↑28.1% | 63↑45.4% | 43↑108.4% | 21 | |
| General & Administrative Expenses | 30↑23.8% | 24↑38.3% | 17↑9.5% | 16↑181.7% | 6 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 30↑23.8% | 24↑38.3% | 17↑9.5% | 16↑181.7% | 6 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 133↑27.4% | 104↑30.3% | 80↑35.7% | 59↑124.2% | 26 | |
| Total Costs & Expenses | 133↑27.4% | 104↑30.3% | 80↑35.7% | 59↑124.2% | 26 | |
| Operating Results | ||||||
| Operating Income | -133↓27.4% | -104↓30.3% | -80↓35.7% | -59↓124.2% | -26 | |
| Depreciation & Amortization | 0.55↑5.2% | 0.52↑45.4% | 0.36↑20.6% | 0.30↑111.4% | 0.14 | |
| EBITDA | -132↓27.6% | -104↓30.2% | -80↓35.7% | -59↓124.2% | -26 | |
| EBIT | -133↓27.4% | -104↓30.3% | -80↓35.7% | -59↓124.2% | -26 | |
| Interest & Other Income | ||||||
| Net Interest Income | 13↓27.6% | 18↑63.7% | 11↑196.0% | 4↑27992.3% | 0.01 | |
| Interest Income | 13↓27.6% | 18↑63.7% | 11↑196.0% | 4↑27992.3% | 0.01 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 13↓27.6% | 18↑63.7% | 11↑200.1% | 4↑60133.3% | -0.01 | |
| Income Before Tax | -120↓38.7% | -86↓25.1% | -69↓25.0% | -55↓110.4% | -26 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -120↓38.7% | -86↓25.1% | -69↓25.0% | -55↓110.4% | -26 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -120↓38.7% | -86↓25.1% | -69↓25.0% | -55↓110.4% | -26 | |
| Bottom-Line Net Income | -120↓38.7% | -86↓25.1% | -69↓25.0% | -55↓110.4% | -26 | |
| EPS (Basic) | -2.01↓33.1% | -1.51↑6.8% | -1.62↓31.7% | -1.23↓95.2% | -0.63 | |
| EPS (Diluted) | -2.01↓33.1% | -1.51↑6.8% | -1.62↓31.7% | -1.23↓95.2% | -0.63 | |
| Weighted Average Shares | 60↑4.2% | 57↑34.0% | 43↑2.0% | 42↑1.1% | 41 | |
| Weighted Average Diluted Shares | 60↑4.2% | 57↑34.0% | 43↑2.0% | 42↑1.1% | 41 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.